dc.contributor.author | Besada, Emilio | |
dc.date.accessioned | 2017-02-21T12:16:49Z | |
dc.date.available | 2017-02-21T12:16:49Z | |
dc.date.issued | 2016-08-10 | |
dc.description | Source: <a href=http://dx.doi.org/10.1080/03009742.2016.1207299>doi: 10.1080/03009742.2016.1207299</a> | en_US |
dc.identifier.citation | Scandinavian Journal of Rheumatology. Supplement 2016, 45:48-48 | en_US |
dc.identifier.cristinID | FRIDAID 1379335 | |
dc.identifier.issn | 0301-3847 | |
dc.identifier.uri | https://hdl.handle.net/10037/10323 | |
dc.language.iso | eng | en_US |
dc.publisher | Taylor & Francis Group | en_US |
dc.rights.accessRights | openAccess | en_US |
dc.subject | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Reumatologi: 759 | en_US |
dc.subject | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Reumatologi: 759 | en_US |
dc.title | Rituximab-induced hypogammaglobulinemia and intravenous immunoglobulin replacement therapy do not protect against relapse in granulomatous with polyangiitis | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |